San Diego-dependent Viking Therapeutics marked alone as a significant competitor while in the weight loss drug market in February immediately after revealing promising information from the mid-stage demo of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when offered for a weekly injection As well as i… Read More